Shanghai Runkey Biotech Co., Ltd showcased innovative cellulose application solutions at CPHI China 2024.‌

 Shanghai，2024-06-19

At the exhibition of CPHI China 2024, Shanghai Runkey Biotech Co., Ltd. ("Runkey Biotech"), a leading enterprise in cellulose applications, showcased its innovative products and solutions, attracting significant attention from numerous domestic and international professionals in the pharmaceutical, food, and industrial sectors.

Focus on Cellulose Applications: Provide Customized Solutions‌

‌ 

Shanghai Runkey Biotech Co., Ltd, since its establishment in 2016, has consistently focused on the research and innovation of cellulose application technology, dedicated to providing customers with efficient and environmentally friendly cellulose solutions. The company's products are widely used in multiple fields such as pharmaceutical excipients, food additives, and industrial materials, and have won the trust of global customers due to their excellent performance and stability.

At this year's CPHI China exhibition, Runkey Biotech showcased its latest cellulose derivative products, including high-performance cellulose ethers and microcrystalline cellulose. These products serve as key excipients in the pharmaceutical industry, significantly enhancing drug solubility, stability, and bioavailability. Meanwhile, the company also introduced customized cellulose solutions for the food industry, helping customers optimize product texture, extend shelf life, and meet increasingly stringent food safety standards.

International Layout, Serving Global Customers

‌‌ 

Runkey Biotech has always adhered to an international development strategy. Its products have been exported to more than 50 countries and regions across Asia, Europe, South America, the Middle East, Africa, and Australia. The company ensures that every batch of products meets international standards through a rigorous ISO 9001 and ISO 14001 quality certification system. At the exhibition site, Runkey Biotech reached preliminary cooperation intentions with several international pharmaceutical enterprises, further consolidating its leading position in the global cellulose market.‌

Looking ahead to the future, continuously empowering the industry.

‌ 

With the growing global emphasis on environmental protection and sustainable development, cellulose, as a renewable resource, has an increasingly broad application prospect. Runkey Biotech will continue to increase investment in R&D and expand the application areas of our products to provide more high-value-added products and services for pharmaceutical, food, and industrial clients.

"We believe that through continuous innovation and international expansion, Runkey Biotech will become a global leader in the field of cellulose applications," said the company's founder. "In the future, we will continue to uphold the philosophy of 'customer-first and innovation-driven' to create more value for our global customers."